Localized enlarged lymph nodes
ICD-10 R59.0 is a billable code used to indicate a diagnosis of localized enlarged lymph nodes.
Localized enlarged lymph nodes, classified under ICD-10 code R59.0, refer to the swelling of lymph nodes in a specific area of the body, which can be indicative of various underlying conditions. These lymph nodes may become enlarged due to infections, autoimmune diseases, malignancies, or other inflammatory processes. Clinically, patients may present with palpable lymphadenopathy, which can be assessed through physical examination. Symptoms may include tenderness, pain, or discomfort in the affected area, and systemic symptoms such as fever, night sweats, or weight loss may also be present, depending on the underlying cause. Laboratory findings may include elevated white blood cell counts, abnormal lymphocyte profiles, or specific markers indicating infection or malignancy. Accurate diagnosis often requires correlation with clinical history, imaging studies, and possibly biopsy of the lymph node to determine the etiology of the enlargement.
Detailed history of present illness, physical examination findings, and any relevant lab results.
Patients presenting with fever and localized lymphadenopathy, possibly indicating an infection.
Consideration of chronic conditions that may lead to persistent lymphadenopathy.
Acute care notes including vital signs, immediate lab results, and any imaging performed.
Acute presentations of lymphadenopathy with systemic symptoms such as fever or rash.
Rapid assessment and documentation of potential life-threatening conditions.
When a lymph node biopsy is performed to evaluate the cause of lymphadenopathy.
Pathology report and clinical notes supporting the need for biopsy.
Oncology may require additional documentation regarding the malignancy workup.
Documentation should include the specific location of the enlarged lymph nodes, associated symptoms, clinical findings, and any relevant diagnostic tests performed.
